phase 2_completion
saveChongqing Medical University Hospital 2 — propofol (Phase II Trial Completion)
community read0 votes
Therapy area: Central Nervous System. Indication: Cognitive Disorders
Data sources
globaldata
Found something off?
drug timeline · 8
- phase 2 completionXijing Hospital — propofol (Phase II Trial Completion)Apr 24, 2026 · 161d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalNov 21, 2025 · 315d ago
- approvalPROPOFOL — FDA approvalSep 19, 2025 · 378d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalAug 31, 2022 · 1493d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalMay 11, 2021 · 1970d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalApr 27, 2017 · 3445d ago
- approvalPROPOFOL — FDA approvalMay 29, 2016 · 3778d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalApr 17, 2015 · 4186d ago
comments(0)
5-min edit window · permanent after that